Vaccination Against Pneumococcus in West Africa: Perspectives and Prospects

This article, published in the International Journal of General Medicine, provides epidemiological insights into pneumococcal conjugate vaccines in West Africa based on the prevailing pneumococcal serotypes in the subregion. The study covered pneumococcal isolates from Burkina Faso, Ghana, Nigeria, Mali, Senegal, and The Gambia. Based on the findings, researchers concluded that pneumococcal serotypes 1 and 5 were the most important serotypes responsible for pneumococcal disease in the region.

Author(s): Donkor ES, Dayie NT, Badoe EV

Published: 2013

  • Visit web page (English)

    (Located at www.dovepress.com)

    Citation: Donkor ES, Dayie NT, Badoe EV. Vaccination Against Pneumococcus in West Africa: Perspectives and Prospects. Pediatric Drugs. 2013;2013(6):757-764.

Resource types: Peer-reviewed journal

Diseases: Pneumococcus

Topics: Disease burden and surveillance

Regions: Africa